INTERNATIONAL healthcare firm, Abbott  will soon be rolling out a revolutionary viral load technological breakthrough the m-PIMA HIV-1/2 VL  viral  load point-of-care test in Zimbabwe. The turnaround time is only  70 minutes, hence increasing the chances of initiating more people on Anti retro Viral Therapy (ART) and eliminating new transmissions. By Michael Gwarisa The move